Radiomics and artificial intelligence in prostate cancer: new tools for molecular hybrid imaging and theragnostics

In prostate cancer (PCa), the use of new radiopharmaceuticals has improved the accuracy of diagnosis and staging, refined surveillance strategies, and introduced specific and personalized radioreceptor therapies. Nuclear medicine, therefore, holds great promise for improving the quality of life of P...

Descripción completa

Detalles Bibliográficos
Autores principales: Liberini, Virginia, Laudicella, Riccardo, Balma, Michele, Nicolotti, Daniele G., Buschiazzo, Ambra, Grimaldi, Serena, Lorenzon, Leda, Bianchi, Andrea, Peano, Simona, Bartolotta, Tommaso Vincenzo, Farsad, Mohsen, Baldari, Sergio, Burger, Irene A., Huellner, Martin W., Papaleo, Alberto, Deandreis, Désirée
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2022
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9198151/
https://www.ncbi.nlm.nih.gov/pubmed/35701671
http://dx.doi.org/10.1186/s41747-022-00282-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9198151/
https://www.ncbi.nlm.nih.gov/pubmed/35701671
http://dx.doi.org/10.1186/s41747-022-00282-0

Ejemplares similares